Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
3,1-Benzothiazines, 1,4-benzodioxines, 1,4-benzoxazines as inhibitors of matriptase-2 : outcome of a focused screening approach
ID
Roydeva, Polya G.
(
Author
),
ID
Beckmann, Anna-Madeleine
(
Author
),
ID
Stirnberg, Marit
(
Author
),
ID
Cesar, Jožko
(
Author
),
ID
Kikelj, Danijel
(
Author
),
ID
Ilaš, Janez
(
Author
),
ID
Gütschow, Michael
(
Author
)
PDF - Presentation file,
Download
(5,58 MB)
MD5: 9208BD180463A4E82F3D3121DEEC33CF
URL - Source URL, Visit
http://www.mdpi.com/1424-8247/9/1/2
Image galllery
Abstract
The liver enzyme matriptase-2 is a multi-domain, transmembrane serine protease with an extracellular, C-terminal catalytic domain. Synthetic low-molecular weight inhibitors of matriptase-2 have potential as therapeutics to treat iron overload syndromes, in particular in patients with β-thalassemia. A sub-library of 64 compounds was screened for matriptase-2 inhibition and several active compounds were identified. (S)-Ethyl 2-(benzyl(3-((4-carbamidoylphenoxy)methyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)amino)-2-oxoacetate ((S)-12) showed an IC$_{50}$ value of less than 10 µM. Structure-activity relationships were discussed and proposals to design new matriptase-2 inhibitors were made.
Language:
English
Keywords:
marine alkaloid
,
Agelas
,
clathrodin
,
oroidin
,
pyrrole-2-aminoimidazole
,
antibacterial
,
benzamidines
,
4H-3
,
1-benzothiazin-4-ones
,
2
,
3-dihydro-1
,
4-benzodioxines
,
3
,
4-dihydro-2H-1
,
4-benzoxazines
,
matriptase-2
,
protease inhibition
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2016
Number of pages:
11 str.
Numbering:
Vol. 9, iss. 1, art. 2
PID:
20.500.12556/RUL-130387
UDC:
543:615.2
ISSN on article:
1424-8247
DOI:
10.3390/ph9010002
COBISS.SI-ID:
4018289
Publication date in RUL:
14.09.2021
Views:
1164
Downloads:
159
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Pharmaceuticals
Shortened title:
Pharmaceuticals
Publisher:
MDPI
ISSN:
1424-8247
COBISS.SI-ID:
517582617
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
01.03.2016
Projects
Funder:
Other - Other funder or multiple funders
Funding programme:
German Research Foundation (DFG)
Project number:
STI 660/1-1
Funder:
Other - Other funder or multiple funders
Funding programme:
University of Bonn, Gender Equality Center, Maria von Linden Program
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back